Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Corneagen

Request full access

Innovative corneal therapeutics and tissue services advancing ocular surgery and patient care

Seattle, United StatesFounded 2016Biotech & Life Sciences

About Corneagen

CorneaGen is a pioneering company in the field of corneal therapeutics and tissue services, dedicated to transforming cornea care through innovative and affordable solutions. The company serves ophthalmologists, surgeons, and healthcare providers, primarily focusing on the ocular surgery market. CorneaGen operates on a business-to-business (B2B) model, providing high-quality corneal tissue, surgical devices, and advanced therapeutic solutions. Revenue is generated through the sale of corneal tissue for transplantation, surgical instruments, and related medical products. The company also invests in research and development to continuously advance corneal care technologies. CorneaGen's commitment to innovation and education is evident through its extensive range of educational videos, webinars, and wet labs designed to support the professional development of eye care specialists. The company also offers reimbursement assistance and adverse reaction reporting to ensure comprehensive support for its clients. Key products include VisionGraft, EndoSerter, and various pre-loaded glass cannulas. CorneaGen's strategic partnerships and collaborations further enhance its ability to deliver cutting-edge solutions to the market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Seattle, United States
Employees
182
Open positions
7
Dealroom signal
81.8/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Innovation Management, Biotechnology, Health Diagnostics, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B, B2C

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Oct 2019 $37M $148M Flying L Partners ↗
DEBTDebt Oct 2019 $25M — Petrichor —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Corneagen website traffic

Latest recorded traffic for Corneagen is 6.3K monthly website visits, up 14.5% over the last three months. Corneagen's team grew 19.7% over the past year.

Latest monthly visits6.3K 3-month web change+14.5% 1-year team growth+19.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Corneagen in the Seattle ecosystem

Live from Dealroom

The Corneagen office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Flying L Partners

Series B and later1 investor entered at this stage

  • Petrichor
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Corneagen on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Corneagen’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.